DUBAI, UAE, Dec. 18, 2023 /PRNewswire/ — The inaugural “Housearch Investment Index” has highlighted the Gulf countries, with Oman, Qatar, and the United Arab Emirates, particularly Dubai, securing top positions for residential property investment in 2024. This trend underscores the region’s appeal as a stable and reliable investment haven, especially amidst cooling property markets in… Continue reading Gulf Countries Dominate Top Positions in New Global Residential Property Investment Ranking for 2024
Category: Newswire
Capital Square Marks Construction Milestone with Topping Out of Trophy Multifamily Tower in Raleigh Opportunity Zone
RALEIGH, N.C., Dec. 18, 2023 /PRNewswire/ — Capital Square, one of the nation’s leading sponsors of tax-advantaged real estate investments and an active developer and manager of housing communities, announced today the topping out of a 20-story Class A multifamily tower at 320 W. South Street in the Warehouse District of Raleigh, North Carolina within a… Continue reading Capital Square Marks Construction Milestone with Topping Out of Trophy Multifamily Tower in Raleigh Opportunity Zone
Canada Nickel Provides Financing Update
TORONTO, Dec. 18, 2023 /PRNewswire/ – Canada Nickel Company Inc. (“Canada Nickel” or the “Company”) (TSXV: CNC) (OTCQX: CNIKF) today announced that it has extended the repayment date of the US$12 million loan facility announced September 18, 2023 with Auramet International, Inc. (“Auramet”) to January 18, 2024 by agreeing to issue 350,000 one year common… Continue reading Canada Nickel Provides Financing Update
Global Menin Inhibitor Drugs Insights Report 2023: Phase-II has the Highest Clinical Trials Phase, 10 Drugs in Clinical Trial, Clinical Significance, and Innovation Trends by US, Europe & Canada
DUBLIN, Dec. 18, 2023 /PRNewswire/ — The “Global Menin Inhibitor Drugs Clinical Trials & Future Opportunity Insight 2023” report has been added to ResearchAndMarkets.com’s offering. Menin represents a new generation of proteins that have found application as a therapeutic target in several prevalent diseases, especially cancer. First linked with benign tumors through the studies on… Continue reading Global Menin Inhibitor Drugs Insights Report 2023: Phase-II has the Highest Clinical Trials Phase, 10 Drugs in Clinical Trial, Clinical Significance, and Innovation Trends by US, Europe & Canada
Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries
10+ Emerging Markets, Japan & ANZ Transition in Final Phase DUBAI, UAE, Dec. 18, 2023 /PRNewswire/ — Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully concluded the integration of the acquired Viatris biosimilars business with the transition of 10+ Emerging Markets and Japan, Australia and… Continue reading Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries
Global Construction Management Software Market to Hit $21.67 Billion by 2030, Registering a Robust 12.50% CAGR, Propelled by Rising Construction Activities Worldwide, States Kings Research
DUBAI, UAE, Dec. 18, 2023 /PRNewswire/ — According to a recent Kings Research study, the global Construction Management Software Market size was recorded at USD 9.45 billion in 2022 and is estimated to grow to USD 21.67 billion by 2030, recording a strong CAGR of 12.50% over the forecast period of 2023-2030. The increase in… Continue reading Global Construction Management Software Market to Hit $21.67 Billion by 2030, Registering a Robust 12.50% CAGR, Propelled by Rising Construction Activities Worldwide, States Kings Research
Ebix Reaches “Stalking Horse” Sale Agreement for Life Insurance and Annuity Business with Zinnia to Ensure Successful Recapitalization Efforts
Company Continues to Have Robust Worldwide Operations and Strong Fundamentals Secures New Financing to Support Restructuring Process Proposed Transaction Provides Ongoing Stability for the Insurance Industry, Ensuring Continued World Class Delivery for Clients JOHNS CREEK, Ga., Dec. 18, 2023 /PRNewswire/ — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of on-demand software and e-commerce services… Continue reading Ebix Reaches “Stalking Horse” Sale Agreement for Life Insurance and Annuity Business with Zinnia to Ensure Successful Recapitalization Efforts
More Than 700 People May Die on U.S. Roads this Holiday Season
During National Impaired Driving Prevention Month, special attention must be paid to one of the leading causes of traffic fatalities in the U.S. WASHINGTON, Dec. 18, 2023 /PRNewswire/ — The National Safety Council estimates 720 people may be killed on U.S. roadways during the upcoming holidays: 345 during the Christmas holiday driving period and an additional 375… Continue reading More Than 700 People May Die on U.S. Roads this Holiday Season
Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
Highlights: Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures Improvements were consistently seen across clinically important aspects of Phelan-McDermid syndrome, including communication, behaviour, cognition/learning and socialisation Clinician and caregiver global efficacy measures showed a level of improvement typically considered clinically meaningful: – Clinical Global Impression of Improvement (CGI-I) –… Continue reading Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
Two Day Online Cosmetovigilance Training Course: Focus on Europe, the USA and the Rest of the World (February 5-6, 2024)
Dublin , Dec. 18, 2023 /PRNewswire/ — The “Cosmetovigilance Training Course” conference has been added to ResearchAndMarkets.com’s offering. The regulations for cosmetic products globally have been in place for nearly 50 years and have been changing and growing worldwide. Previously there had not been a requirement to test cosmetics in the same manner as medicines because of perceived lack… Continue reading Two Day Online Cosmetovigilance Training Course: Focus on Europe, the USA and the Rest of the World (February 5-6, 2024)